2021
DOI: 10.1007/s11845-021-02604-4
|View full text |Cite
|
Sign up to set email alerts
|

Research progress in laboratory detection of SARS-CoV-2

Abstract: Background Nucleic acid testing is a reliable method for diagnosing viral infection in clinical samples. However, when the number of cases is huge and there are individual differences in the virus itself, the probability of false-negative results increases. With the advancement in research on the new coronavirus, new detection technologies that use serum-specific antibodies as detection targets have been developed. These detection technologies have high efficiency and shorter turnaround time, whic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 45 publications
0
5
0
Order By: Relevance
“…16 Another reported an 11% decrease in EBF in the newborn nursery during the postpartum hospitalization. 17…”
Section: Discussionmentioning
confidence: 99%
“…16 Another reported an 11% decrease in EBF in the newborn nursery during the postpartum hospitalization. 17…”
Section: Discussionmentioning
confidence: 99%
“…During the process or at the end point for detection, fluorescent signals are read. Wang et al. (2021) evaluated the quality of 6 approved commercial nucleic acid assay kits, and the results showed that the lower limits of these kits differed greatly ( Wang et al., 2020 ).…”
Section: Methods Of Natmentioning
confidence: 99%
“…Therefore, the monitoring of new variants and the possible impacts of transmission, pathogenicity and immune evasion are the focus of current pandemic prevention and control. Real-time fluorescence quantitative PCR nucleic acid detection has high specificity and sensitivity and has become the “gold standard” for diagnosing SARS-CoV-2 infection ( Wang H. et al, 2022 ). However, because SARS-CoV-2 is an RNA virus, variation in the target sequence develops easily, and too low a viral content in the sample to be detected due to weakening of the virus shedding ability and even some inappropriate operations (including sample collection, transportation, storage and processing, etc.)…”
Section: Establish a Mode To Cope With The Covid-19 Epidemicmentioning
confidence: 99%